CARA DEBUSK: Open Payments
NPI 1790015600 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$831 in 31 payments from 11 companies in 2025. Trend: 2023 $930 · 2024 $853 · 2025 $831
Food & beverage: $831
| Company | Payments | Amount |
|---|---|---|
| CSL Behring | 9 | $240 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $188 |
| GlaxoSmithKline, LLC. | 4 | $93 |
| Regeneron Healthcare Solutions, Inc. | 2 | $73 |
| Novartis Pharmaceuticals Corporation | 2 | $69 |
| Ionis Pharmaceuticals, Inc. | 1 | $39 |
| Genentech USA, Inc. | 1 | $39 |
| Blueprint Medicines Corporation | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $26 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $24 |
Products named: HYQVIA, Hizentra, NUCALA, Andembry, DUPIXENT, Haegarda, DAWNZERA, Xolair.
Industry payments across FL — which companies pay providers there.
